Friday, November 11, 2016

BRIEF-Cellectar Biosciences Inc Q3 loss from operations was $2.5 million

* Continues to estimate that its available cash and cash

equivalents will fund its planned operations into Q1 of 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)